Efficacy and safety of Nab-paclitaxel in breast cancer: a meta-analysis
View ORCID ProfileUpendra Yadav, View ORCID ProfilePradeep Kumar, View ORCID ProfileVandana Rai
doi: https://doi.org/10.1101/19008672
Upendra Yadav
Human Molecular Genetics Laboratory, Department of Biotechnology, VBS Purvanchal University, Jaunpur (UP)– 222 003, India
Pradeep Kumar
Human Molecular Genetics Laboratory, Department of Biotechnology, VBS Purvanchal University, Jaunpur (UP)– 222 003, India
Vandana Rai
Human Molecular Genetics Laboratory, Department of Biotechnology, VBS Purvanchal University, Jaunpur (UP)– 222 003, India

Article usage
Posted October 16, 2019.
Efficacy and safety of Nab-paclitaxel in breast cancer: a meta-analysis
Upendra Yadav, Pradeep Kumar, Vandana Rai
medRxiv 19008672; doi: https://doi.org/10.1101/19008672
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)